EP2351764A8 - Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé - Google Patents

Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé Download PDF

Info

Publication number
EP2351764A8
EP2351764A8 EP09823291A EP09823291A EP2351764A8 EP 2351764 A8 EP2351764 A8 EP 2351764A8 EP 09823291 A EP09823291 A EP 09823291A EP 09823291 A EP09823291 A EP 09823291A EP 2351764 A8 EP2351764 A8 EP 2351764A8
Authority
EP
European Patent Office
Prior art keywords
compound
trehalose
product containing
pharmaceutical product
producing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09823291A
Other languages
German (de)
English (en)
Other versions
EP2351764A1 (fr
EP2351764A4 (fr
Inventor
Mugio Nishizawa
Hiroshi Imagawa
Hirofumi Yamamoto
Jun Sakurai
Masataka Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Priority to EP12190302A priority Critical patent/EP2567963A1/fr
Publication of EP2351764A1 publication Critical patent/EP2351764A1/fr
Publication of EP2351764A8 publication Critical patent/EP2351764A8/fr
Publication of EP2351764A4 publication Critical patent/EP2351764A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EP09823291A 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé Withdrawn EP2351764A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP12190302A EP2567963A1 (fr) 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008282613 2008-10-31
JP2009046824 2009-02-27
PCT/JP2009/005650 WO2010050178A1 (fr) 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé

Publications (3)

Publication Number Publication Date
EP2351764A1 EP2351764A1 (fr) 2011-08-03
EP2351764A8 true EP2351764A8 (fr) 2011-09-21
EP2351764A4 EP2351764A4 (fr) 2012-09-05

Family

ID=42128548

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09823291A Withdrawn EP2351764A4 (fr) 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé
EP12190302A Withdrawn EP2567963A1 (fr) 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP12190302A Withdrawn EP2567963A1 (fr) 2008-10-31 2009-10-27 Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé

Country Status (7)

Country Link
US (2) US8741871B2 (fr)
EP (2) EP2351764A4 (fr)
JP (1) JP5552056B2 (fr)
KR (1) KR20110082584A (fr)
CN (1) CN102203110A (fr)
TW (1) TW201016221A (fr)
WO (1) WO2010050178A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101914118B (zh) * 2010-08-06 2012-07-04 山东大学 海藻糖衍生物及其制备方法与应用
CN105164204A (zh) 2012-11-21 2015-12-16 路易斯维尔大学研究基金会 用于降低氧化损伤的组合物和方法
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
KR20160009617A (ko) 2013-05-07 2016-01-26 바이오 블라스트 파마 리미티드 트레할로스의 비경구 투여에 의한 단백질 응집 근병증 및 신경퇴행성 질환의 치료
JP6130224B2 (ja) * 2013-05-27 2017-05-17 公益財団法人微生物化学研究会 新規化合物レンツトレハロース、その製造方法、及びその用途、並びに、新規微生物
EP3256136A4 (fr) 2015-02-09 2018-11-21 University Of Louisville Research Foundation, Inc. Compositions ophtalmiques et procédés de réduction des dommages oxydatifs d'un cristallin oculaire
CZ309423B6 (cs) * 2016-06-06 2022-12-28 Apigenex S.R.O. Lipofilní deriváty trehalózy, jejich příprava a farmaceutická využitelnost
EP3710462A4 (fr) * 2017-11-02 2021-08-25 Victoria Link Limited Analogues de brartémicine
EP3755342A4 (fr) * 2018-02-21 2021-11-24 The University Of Montana Composés de tréhalose de diaryle et leurs utilisations
WO2019197595A2 (fr) 2018-04-13 2019-10-17 Glaxosmithkline Biologicals Sa Composés et utilisations
CN110501483B (zh) * 2019-07-25 2020-12-29 同济大学 一种中草药活性的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58185599A (ja) * 1982-04-26 1983-10-29 Ss Pharmaceut Co Ltd α，α―トレハロース―６，６′―脂肪酸ジエステルの製造方法
CA1202622A (fr) * 1982-10-14 1986-04-01 Yoshihiro Nishikawa DIESTER D'UN ACIDE ALIPHATIQUE A CHAINE DE LONGUEUR MOYENNE ET DE .alpha.-.alpha.-TREHALOSE-6,6' ET AGENT PHARMACEUTIQUE LE CONTENANT
JPS59181297A (ja) * 1984-03-01 1984-10-15 Ss Pharmaceut Co Ltd α，α‐トレハロース‐６，６′‐中鎖脂肪酸ジエステル及びこれを含有する抗腫瘍剤
JPS6253926A (ja) 1985-05-30 1987-03-09 Ss Pharmaceut Co Ltd 抗癌剤
JP3326059B2 (ja) * 1995-10-05 2002-09-17 カネボウ株式会社 皮膚化粧料
JPH09188603A (ja) * 1996-01-08 1997-07-22 Kanebo Ltd 皮膚化粧料
JPH11171727A (ja) * 1997-09-30 1999-06-29 Kanebo Ltd 身体洗浄剤組成物
JP4639055B2 (ja) * 2004-05-20 2011-02-23 公益財団法人野口研究所 ベロ毒素中和剤としてのスフィンゴ糖脂質類似体
JP5114627B2 (ja) * 2006-03-27 2013-01-09 株式会社糖鎖工学研究所 トレハロース化合物および該化合物を含有する医薬
JP5258582B2 (ja) 2007-01-31 2013-08-07 株式会社糖鎖工学研究所 トレハロース化合物、その製造方法、及び該化合物を含有する免疫賦活剤

Also Published As

Publication number Publication date
TW201016221A (en) 2010-05-01
JP5552056B2 (ja) 2014-07-16
US20140248317A1 (en) 2014-09-04
US20110218171A1 (en) 2011-09-08
EP2351764A1 (fr) 2011-08-03
CN102203110A (zh) 2011-09-28
KR20110082584A (ko) 2011-07-19
US8741871B2 (en) 2014-06-03
EP2567963A1 (fr) 2013-03-13
EP2351764A4 (fr) 2012-09-05
WO2010050178A1 (fr) 2010-05-06
JPWO2010050178A1 (ja) 2012-03-29

Similar Documents

Publication Publication Date Title
EP2351764A8 (fr) Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé
MY149180A (en) Uracil compound having inhibitor activity on human deoxyuridine triphosphatase or salt thereof
WO2006105888A3 (fr) Combinaisons d'agents actifs fongicides synergiques
WO2009069296A1 (fr) Agent d'élimination d'un biolfilm
MY168201A (en) Agricultural And Horticultural Fungicidal Composition
TW200740758A (en) Benzoquinazoline derivatives
MX363956B (es) Agente de control de plagas.
MY147211A (en) Novel dihydropseudoerythromycin derivatives
EA017861B9 (ru) Способ получения 4-оксохинолинового соединения
IN2014CN00712A (fr)
WO2008108378A3 (fr) Dérivé bicyclique d'oxomorpholine
PL2090570T3 (pl) Pochodna imidazolu
WO2009082152A3 (fr) Activateurs de la glucokinase et compositions pharmaceutiques contenant ces derniers en tant qu'ingrédient actif
WO2007118198A8 (fr) ANALOGUES DE LA 2-MÉTHYLÈNE-1α,25-DIHYDROXY-19,21-DINOR-VITAMINE D3 ET LEURS UTILISATIONS
WO2011054436A3 (fr) Amides substitués par halogènalkyle utilisés comme insecticides et acaricides
WO2011004162A3 (fr) Composés utilisés en tant que médicaments
EP1634874A4 (fr) Derive d'imidazolidine
EP3216798A3 (fr) Composés kétolides
WO2012134184A3 (fr) Nouveau dérivé de céphalosporine et composition médicale le contenant
WO2009064374A8 (fr) Formulations orales de bis(thiohydrazideamides)
WO2007080270A3 (fr) Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
BR112013015604A2 (pt) novo derivado de isoquinolina substituído
PL1970372T3 (pl) Sole kwasu 9-oksoakrydyno-10-octowego z 1-alkiloamino-1-deoksypoliolami
WO2010061938A3 (fr) Composition permettant de lutter contre des maladies de plantes et procédé permettant de lutter contre des maladies de plantes
WO2012134188A3 (fr) Nouveau dérivé d'oxazolidinone et composition médicale le contenant

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110531

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: NISHIZAWA, MUGIO

Inventor name: SAKURAI, JUN

Inventor name: YAMAMOTO, HIROFUMI

Inventor name: ODA, MASATAKA

Inventor name: IMAGAWA, HIROSHI

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120710

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20120704BHEP

Ipc: A61P 39/02 20060101ALI20120704BHEP

Ipc: A61P 37/04 20060101ALI20120704BHEP

Ipc: A61K 31/7024 20060101ALI20120704BHEP

Ipc: C07H 13/06 20060101AFI20120704BHEP

Ipc: A61P 31/04 20060101ALI20120704BHEP

Ipc: C07H 13/08 20060101ALI20120704BHEP

Ipc: A61P 31/00 20060101ALI20120704BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20120726

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20121031